Market Cap

$1.3B

Volume

1.7M

Cash and Equivalents

$149.0M

EBITDA

-$143.3M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

-$67.8M

Profit Margin

N/A

52 Week High

$42.20

52 Week Low

$8.79

Dividend

N/A

Price / Book Value

7.59

Price / Earnings

-19.21

Price / Tangible Book Value

7.60

Enterprise Value

$1.1B

Enterprise Value / EBITDA

-7.82

Operating Income

-$144.5M

Return on Equity

-10.98%

Return on Assets

-45.59

Cash and Short Term Investments

$149.0M

Debt

N/A

Equity

$166.6M

Revenue

N/A

Unlevered FCF

-$82.6M

Sector

Pharmaceuticals

Category

N/A